HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...
There is growing evidence that pre-exposure prophylaxis (PrEP) prevents HIV acquisition. However, in the United States, approximately only 4% of people who could benefit from PrEP are currently ...
A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...
Health and Me on MSN
Rabies pre-exposure prophylaxis vaccine can protect you even before a dog bite—here’s how
Rabies is a deadly viral infection, mostly spread by dog bites. Here’s how the rabies pre-exposure prophylaxis vaccine works, ...
Oral HIV pre-exposure prophylaxis (PrEP) is highly effective for preventing HIV. Several different developments in the US either threaten to increase or promise to decrease PrEP out-of-pocket costs ...
The "Follow at Your Own Pace" campaign was launched at the Vicente García Memorial. This national initiative aims to ...
Lenacapavir, a twice-yearly injectable, offers a new HIV prevention method, improving adherence compared to more frequent regimens. Phase 3 trials showed lenacapavir's high efficacy in preventing HIV, ...
The Centers for Disease Control and Prevention (CDC), on behalf of the U.S. Public Health Service (PHS), has released the 2025 Guidelines for the Management of Occupational Exposure to Human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback